-
Tetrahydrocannabinol Analogues
8-Oxo-Δ9-THC is an oxygenated analog of tetrahydrocannabinol that exhibits significant interaction with cannabinoid receptors in the endocannabinoid system. This compound demonstrates notable biological activity, which may influence various cellular signaling pathways involved in pain modulation, inflammation, and neuroprotection. Its potential applications include research into therapeutic effects associated with cannabinoid compounds as well as studies investigating the pharmacological properties of cannabis-derived substances. -
Drug Derivative
1(R)-Tetrahydrocannabidiol is a drug derivative known for its interaction with cannabinoid receptors. It exhibits potential neuroprotective activity, making it a valuable tool for investigating neurological diseases and disorders. This compound facilitates research into the therapeutic effects of cannabinoids in various neurobiological contexts. -
Active Molecule
WAY-271999 is an active molecule that serves as a potent antagonist of the cannabinoid receptor type 1 (CB1). It exhibits significant modulation of neuropsychiatric and metabolic processes, making it a valuable tool for research in obesity, addiction, and mood disorders. This compound is suitable for in vitro and in vivo studies aimed at elucidating the role of CB1 signaling in various physiological and pathological conditions. -
Cannabinoid Compound
Δ8-THCO (delta 8-tetrahydrocannabinol) is a cannabinoid compound derived from Cannabis sativa. This compound exhibits psychoactive properties akin to delta-9-THC, engaging with the CB1 cannabinoid receptor, which is implicated in various physiological processes such as appetite, pain sensation, and mood regulation. Δ8-THCO is utilized in research focused on understanding the effects of cannabinoids on the endocannabinoid system and exploring potential therapeutic applications in pain management and anxiety treatment. -
Phytocannabinoid
Δ9-Tetrahydrocannabivarinic acid (THCVA) is a phytocannabinoid that acts primarily on cannabinoid receptors, influencing various physiological processes. It exhibits potential anti-inflammatory properties and may play a role in modulating appetite and pain perception. THCVA is of interest in research relating to the therapeutic applications of cannabinoids in treating metabolic disorders and neurological conditions. -
Tetrahydrocannabinol Derivative
Δ9-THC-Ethyl is a derivative of Tetrahydrocannabinol (THC) featuring an ethyl chain modification. This compound primarily targets cannabinoid receptors and exhibits significant psychoactive properties. It is used in research to explore the pharmacological effects of cannabinoids, their therapeutic potential, and to study their role in various physiological processes. -
AEA Prodrug Analog
R-1 Methanandamide Phosphate is a water-soluble prodrug analog of arachidonylethanolamide (AEA), which acts primarily on cannabinoid receptors. This compound exhibits biological activity by enhancing the effects of endocannabinoids, providing insights into cannabinoid signaling pathways. It is suitable for research applications involving the study of the endocannabinoid system and its role in various physiological processes. -
Active Molecule
WAY-604603 is an active molecule that functions primarily as an allosteric modulator of the cannabinoid receptor 1 (CB1). It has demonstrated potential in influencing appetite regulation and neuroprotection. This compound is utilized in research exploring the endocannabinoid system and its implications in metabolic disorders and CNS functions. -
Phytocannabinoids Derivative
Cannabigerol monomethyl ether is a monomethyl ether derivative of the phytocannabinoid, cannabigerol. It exhibits potential biological activity by modulating cannabinoid receptors, thereby influencing a variety of physiological processes. This compound is suitable for research applications focusing on the endocannabinoid system, pharmacological studies of cannabinoids, and elucidation of their therapeutic effects. -
Lipid
(−)-11-hydroxy-Δ8-THC is a phytocannabinoid that acts primarily as a cannabinoid receptor inhibitor. This compound exhibits significant biological activity in modulating lipid signaling pathways. It is utilized in research applications focused on neuropharmacology and the therapeutic potential of cannabinoids in various medical conditions.
-
Stable Isotope
N-Pentylindole-d11 is a deuterated analogue of 1-Pentyl-1H-indole, serving as a stable isotope. This compound is particularly valuable in pharmacokinetic studies, as it aids in tracing the metabolic pathways of indole-based compounds. Its application extends to the analysis of drug metabolism and the study of cannabinoid receptors, enhancing the understanding of biological mechanisms in related research fields. -
Stable Isotope
Anandamide-d4 is a deuterium-labeled derivative of Anandamide, which serves as a stable isotope standard for research applications. This compound is primarily utilized in studies investigating the endocannabinoid system and its physiological effects, enabling precise quantification in metabolic and pharmacokinetic analyses. It aids researchers in elucidating cannabinoid receptor interactions and the role of endocannabinoids in various biological processes. -
Isomer of 5-Fluoro PB-22
5-Fluoro PB-22 6-hydroxyisoquinoline isomer is a structural isomer of the synthetic cannabinoid 5-Fluoro PB-22, acting primarily as a cannabinoid receptor agonist. This compound exhibits significant binding affinity for CB1 and CB2 receptors, contributing to its potential biological effects. It can be utilized in research applications aimed at investigating the biochemical pathways and pharmacological effects of synthetic cannabinoids. -
Isomer of 5-Fluoro PB-22
5-Fluoro PB-22 N-(3-fluoropentyl) isomer is a structural isomer of 5-Fluoro PB-22, targeting the cannabinoid receptors. This compound exhibits significant biological activity related to the modulation of cannabinoid receptor signaling pathways. It is primarily utilized in research applications exploring cannabinoid pharmacology, drug interaction studies, and the development of therapeutic agents targeting the endocannabinoid system. -
Isomer of 5-Fluoro PB-22
5-Fluoro PB-22 5-hydroxyisoquinoline isomer is a structural isomer of 5-Fluoro PB-22, targeting the cannabinoid receptors. This compound has been studied for its potential biological activities within the endocannabinoid system. It may be utilized in research related to neuropharmacology and the exploration of cannabinoid receptor modulation. -
Isomer of PB-22
PB-22 6-Hydroxyquinoline isomer is a structural isomer of the cannabinoid PB-22, which primarily acts on the cannabinoid receptors. This compound may exhibit similar biological activities related to modulation of the endocannabinoid system, potentially influencing pain, inflammation, and mood regulation. It is suitable for research applications in pharmacology, toxicology, and cannabinoid receptor studies. -
Isomer of PB-22
PB-22 7-Hydroxyquinoline isomer is a structural isomer of PB-22, a synthetic cannabinoid. This compound targets cannabinoid receptors and exhibits activity that may influence the endocannabinoid system. PB-22 7-Hydroxyquinoline isomer is primarily utilized in cannabinoid research to explore its pharmacological properties and potential therapeutic applications. -
Isomer of PB-22
PB-22 8-Hydroxyisoquinoline isomer is a structural isomer of the synthetic cannabinoid PB-22. This compound acts primarily on cannabinoid receptors, modulating various signaling pathways. Its unique structure may offer insights into cannabinoid research and the development of novel therapeutic agents targeting the endocannabinoid system. PB-22 8-Hydroxyisoquinoline isomer is suitable for biochemical assays and pharmacological studies exploring cannabinoid receptor interactions. -
Isomer of PB-22
PB-22 5-Hydroxyquinoline isomer is a structural isomer of PB-22, a synthetic cannabinoid. This compound exhibits biological activity related to cannabinoid receptor modulation, making it relevant for pharmacological studies in endocannabinoid signaling pathways. Research applications include investigating the effects of synthetic cannabinoids on neural activity and their potential therapeutic uses in pain management and other neuropsychiatric conditions. -
Isomer of PB-22
PB-22 6-Hydroxyisoquinoline isomer is a structural isomer of PB-22, a synthetic cannabinoid. This compound exhibits cannabinoid receptor activity, thereby influencing endocannabinoid signaling pathways. It is primarily utilized in research settings to study the pharmacological effects of cannabinoid compounds and their potential therapeutic applications. -
Isomer of 5-Fluoro PB-22
5-Fluoro PB-22 N-(4-fluoropentyl) isomer is a structural isomer of 5-Fluoro PB-22 that acts as a potent cannabinoid receptor agonist. This compound exhibits biological activities that may modulate cannabinoid signaling pathways, making it relevant for research in neuropharmacology and cannabinoid receptor biology. Its unique profile allows for investigations into the effects of synthetic cannabinoids on physiological and psychological processes. -
Isomer of PB-22
PB-22 5-Hydroxyisoquinoline isomer is a structural isomer of the cannabinoid PB-22, targeting cannabinoid receptors in the central nervous system. This compound exhibits potential neuropharmacological activity, making it suitable for research into cannabinoids and their effects on various biological processes. Its unique structure allows for the exploration of the functional relationships between different isomers and their associated biological activity in preclinical studies. -
Isomer of 5-Fluoro PB-22
5-Fluoro PB-22 6-hydroxyquinoline isomer is a structural isomer of 5-Fluoro PB-22, targeting cannabinoid receptors in the endocannabinoid system. This compound is utilized in research focused on cannabinoid receptor modulation and the investigation of its pharmacological effects. Its unique structure allows for the exploration of potential therapeutic applications and the study of receptor binding dynamics. -
Isomer of 5-Fluoro PB-22
5-Fluoro PB-22 7-hydroxyisoquinoline isomer is a structural isomer of 5-Fluoro PB-22, primarily known for its activity at cannabinoid receptors. This compound exhibits potential in studying the effects of structural variations on cannabinoid receptor function and related signaling pathways. It is applicable in research focused on pharmacology, neuroscience, and the characterization of synthetic cannabinoids. -
Isomer of PB-22
PB-22 7-Hydroxyisoquinoline isomer is a structural isomer of the cannabinoid PB-22. This compound exhibits potential biological activity by interacting with cannabinoid receptors, which play a crucial role in various physiological processes. Research applications include studies on cannabinoid receptor signaling and exploration of therapeutic effects in neurological and inflammatory disorders. -
Cannabinoid Receptor Agonist
β-Caryophyllene is a potent agonist of the cannabinoid receptor type 2 (CB2). This compound is known for its anti-inflammatory and analgesic properties, making it a valuable tool in research focused on pain management and the endocannabinoid system. Additionally, β-Caryophyllene can be used to explore therapeutic applications in various disease models, including neurodegeneration and immune response studies. -
Cytochrome P450 Inhibitor
Olivetol is a naturally occurring phenol that functions as a competitive inhibitor of cytochrome P450 enzymes, specifically CYP2C19 and CYP2D6, with IC50 values of 15.3 μM and 7.21 μM, respectively. Additionally, olivetol has demonstrated inhibitory activity against cannabinoid receptors CB1 and CB2. This compound is useful in research related to drug metabolism, pharmacokinetics, and the modulation of cannabinoid signaling pathways. -
Ester Product
Arachidoyl ethanolamide is an ester derivative of arachidonic acid that functions primarily as a bioactive lipid mediator. It is known to modulate various physiological processes by interacting with cannabinoid receptors and has potential implications in pain modulation and inflammation. This compound is utilized in research to investigate endocannabinoid signaling pathways and their roles in various biological systems.

